Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo

American Journal of Pathology

Volumn 156, Issue 4, 2000, Pages 1469-1476

  Arbiser, Jack L ^a   Larsson, Helena ^b   Claesson Welsh, Lena ^b   Bai, Xianhe ^a   LaMontagne, Kenneth ^c   Weiss, Sharon W ^a   Soker, Shai ^c   Flynn, Evelyn ^c   Brown, Lawrence F ^d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; VASCULOTROPIN;

ANGIOGENESIS; ANGIOSARCOMA; ANIMAL CELL; ARTICLE; GENE EXPRESSION; HEMANGIOMA; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; SOLID TUMOR;

EID: 0033843607     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65015-8     Document Type: Article

References (46)

1. Birthmarks in infants
2. Kaposiform hemangioendothelioma: A locally invasive vascular tumor that can mimic hemangioma of infancy
3. Cutaneous angiosarcoma of the head and neck: A therapeutic dilemma
4. Successful multimodal therapy for kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon: Case report and review of the literature
5. Angiosarcoma in primary lymphedema of the lower extremity-Stewart-Treves syndrome
6. Post-treatment sarcoma in breast cancer patients
7. Genetic risks of vinyl chloride
8. Sporadic and thorotrast induced hepatic angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2
9. p53 gene mutation pattern in rat liver tumors induced by vinyl chloride
10. p53 gene mutation pattern in rat liver tumors induced by vinyl chloride
11. Cutaneous angiosarcoma arising in the radiation site of a congenital hemangioma
12. Lymphangiosarcoma following mastectomy
13. Kaposiform hemangioendothelioma of infancy and childhood: An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis
14. Radiation-induced sarcoma after breast cancer: Apropos of 8 cases and review of the literature
15. Oncogenic H-Ras stimulates tumor angiogenesis by two distinct pathways
16. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor
17. Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat
18. Vascular permebility factor mRNA and protein expression in human kidney
19. Expression of Vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis
20. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor
21. Ets-1 regulates angiogenesis by inducing the express on of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells
22. Structure and function of vascular endothelial growth factor receptor-1 and -2
23. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
24. The biology of vascular endothelial growth factor
25. Mutant ras oncogenes upregulate VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis
26. Both v-Ha-ras and v-raf stimulate expression of the vascular endothelial growth factor in NIH3TS cells
27. Hypoxic induction of human vascular endothelial growth factor expression through c-src activation
28. Post-translational regulation of vascular endothelial growth factor by hypoxia
29. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spehroids: Implications for tumor angiogenesis
30. Wild type p53 and v-src exert opposing influences on human vascular endothelial growth factor gene expression
31. Establishing a link between oncogenes and tumor angiogenesis
32. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo Angiogenic implications for signal transduction therapy of solid tumors
33. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol-3-kinase/Akt signal transduction pathway: Requirement for flk-1/kdr activation
34. Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor
35. Role of the fit-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
36. Failure of blood-island formation and vasculogenesis in flk-1 deficient mice
37. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase c-gamma and migration of endothelial cells expressing flt-1
38. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF 165 in patient with ischaemic limb
39. Cellular markers that distinguish the phases of hemangioma during infancy and childhood
40. MDM-2 Oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas
41. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS associated Kaposi's sarcoma and cutaneous angiosarcoma
42. Overexpression of vascular endothelial growth factor induces cell transformation in cooperation with fibroblast growth factor 2
43. Compartmentalization of autocrine signal transduction pathways in Sis transformed NIH 3T3 cells
44. Synthesis and biologic evaluation s of 3-substituted indolin-2-ones: A novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases
45. P53 mutations at AT base pairs in primary hepatic angiosarcomas not associated with vinyl chloride exposure
46. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours